Τετάρτη 13 Απριλίου 2016

A Pilot Study at a Single-Institution of Pregabalin in the Management of Mucositis Pain in Patients Undergoing Chemoradiation Therapy to the Head and Neck.

Conditions:   Oropharyngeal Cancer;   Squamous Cell Carcinoma to the Head and Neck
Intervention:   Drug: Lyrica 300 mg
Sponsor:   Abramson Cancer Center of the University of Pennsylvania
Recruiting - verified April 2016

from #ENT via xlomafota13 on Inoreader http://ift.tt/25ZKVAA
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου